Alphyn Secures FDA Clearance of Investigational New Drug Application for Atopic Dermatitis Treatment
ANNAPOLIS, Md., Feb. 19, 2025 /PRNewswire/ -- Alphyn, a…
Read More
CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today…
Read More
Britecyte’s Adipose Tissue Allograft Earns “Safe to Proceed” Status from FDA
GERMANTOWN, Md.--(BUSINESS WIRE)--Amarex today announced its…
Read More
Elixirgen Therapeutics Granted FDA Orphan Drug Designation for EXG-34217 for Treatment of Telomere Biology Disorders
BALTIMORE, Feb. 20, 2025 (GLOBE NEWSWIRE)…
Read More
Georgetown Research and Innovation Showcase: Connecting Academia, Industry, and Investors
On April 1, 2025, Georgetown University’s…
Read More
Governor Moore Names Harry Coker, Jr. as Maryland Department of Commerce Secretary
BALTIMORE, MD (January 24, 2025) – Governor Wes…
Read More
TEDCO Invests in Novel Microdevices
Maryland-founded healthcare company continues to lead…
Read More
BHI Board Member Juergen Klenk Discusses the Future of AI in Federal Health with Deloitte AI Institute
The Deloitte AI Institute has launched…
Read More
Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment
Collaboration Aims to Develop First Intranasal…
Read More
Children’s National and Compremium partner on pediatric medtech innovation
WASHINGTON, DC / BERN, SWITZERLAND -…
Read More
GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader…
Read More
Baltimore’s Elixirgen Therapeutics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation
BALTIMORE, Feb. 13, 2025 (GLOBE NEWSWIRE)…
Read More
SSTI – Useful Stats: Which businesses are potentially impacted by the NIH F&A rate change?
By Conor Gowder & Mark Skinner…
Read More